Elysium's CEO and Chief Scientist explain how the company's latest NAD+ boosters are making human longevity more accessible ...

OpenAI CEO Sam Altman has rejected rival Elon Musk's takeover bid of over $97 billion. Altman stated, “We are not for sale” ...

OpenAI’s new model, called GPT-4b micro, was trained to suggest ways to re-engineer the protein factors to increase their ...

Sam Altman, the CEO of OpenAI, now says he is more confident of ... It covers many disruptive technology and trends including Space, Robotics, Artificial Intelligence, Medicine, Anti-aging ...

Hindustan Aeronautics Limited (HAL) is developing CATS Warrior, an indigenous India's new wingman drone. The unmanned combat ...

Some of the investment will come from OpenAI CEO Sam Altman, who also provided the initial $180 million ... Jeff Bezos contributed to anti-aging startup Alto Labs, while Peter Thiel gave to the ...

The $97.4 billion bid by Elon Musk and his consortium to acquire OpenAI is likely a move to delay and complicate OpenAI's ...

To meet the demand of AI data centers, Florida cannot be reliant on only one or two sources of fuel. A return to American ...

The project emerged from a collaboration between OpenAI and Retro Biosciences, a startup funded with $180 million by Sam Altman, OpenAI's CEO. Retro Biosciences aims to extend human lifespan by ten ...